Celcuity Stock (NASDAQ: CELC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 236.526K |
Day Range | - - - |
52 Wk Range | 8.389 - 22.188 |
Market Cap | $538.107M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 7.21% |
Days to Cover | 6.88 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Celcuity (NASDAQ: CELC) through any online brokerage.
Other companies in Celcuity’s space includes: Cabaletta Bio (NASDAQ:CABA), KalVista Pharma (NASDAQ:KALV), Humacyte (NASDAQ:HUMA), Valneva (NASDAQ:VALN) and Korro Bio (NASDAQ:KRRO).
The latest price target for Celcuity (NASDAQ: CELC) was reported by Needham on Friday, April 12, 2024. The analyst firm set a price target for 24.00 expecting CELC to rise to within 12 months (a possible 35.82% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Celcuity (NASDAQ: CELC) is $17.67 last updated May 3, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Celcuity.
Celcuity’s Q1 earnings are confirmed for Tuesday, May 21, 2024.
There is no upcoming split for Celcuity.
Celcuity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.